Year All2024 May 8, 2024 Q1 2024 Financial Results Unaudited Condensed Consolidated Interim Financial Statements for the Three Months Ended March 31, 2024 228.2 KB Management Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2024 207.1 KB April 22, 2024 Oculis Supplement to Prospectus Nasdaq Iceland Main Market Listing Oculis Supplement to Prospectus Nasdaq Iceland Main Market Listing 802.1 KB April 11, 2024 Oculis Prospectus Nasdaq Iceland Main Market Listing Oculis Prospectus Nasdaq Iceland Main Market Listing 2.1 MB
May 8, 2024 Q1 2024 Financial Results Unaudited Condensed Consolidated Interim Financial Statements for the Three Months Ended March 31, 2024 228.2 KB Management Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2024 207.1 KB
Unaudited Condensed Consolidated Interim Financial Statements for the Three Months Ended March 31, 2024 228.2 KB Management Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2024 207.1 KB
April 22, 2024 Oculis Supplement to Prospectus Nasdaq Iceland Main Market Listing Oculis Supplement to Prospectus Nasdaq Iceland Main Market Listing 802.1 KB
April 11, 2024 Oculis Prospectus Nasdaq Iceland Main Market Listing Oculis Prospectus Nasdaq Iceland Main Market Listing 2.1 MB